Differentiation of Bone Marrow Mesenchymal Stem Cells in Osteoblasts and Adipocytes and Its Role in Treatment of Osteoporosis

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2016 Jan 23

PMID 26795027

Citations 82

Authors

Cheng Wang

Haoye Meng

Xin Wang

Chenyang Zhao

Jing Peng

Yu Wang

Affiliations

Soon will be listed here.

Abstract

Osteoporosis is a systemic metabolic bone disorder characterized by a decrease in bone mass and degradation of the bone microstructure, leaving bones that are fragile and prone to fracture. Most osteoporosis treatments improve symptoms, but to date there is no quick and effective therapy. Bone marrow mesenchymal stem cells (BMMSCs) have pluripotent potential. In adults, BMMSCs differentiate mainly into osteoblasts and adipocytes in the skeleton. However, if this differentiation is unbalanced, it may lead to a decrease in bone mass. If the number of adipocyte cells increases and that of osteoblast cells decreases, osteoporosis can result. A variety of hormones and cytokines play an important role in the regulation of BMMSCs bidirectional differentiation. Therefore, a greater understanding of the regulation mechanism of BMMSC differentiation may provide new methods to prevent and treat osteoporosis. In addition, autologous, allogeneic BMMSCs or genetically modified BMMSC transplantation can effectively increase bone mass and density, increase bone mechanical strength, correct the imbalance in bone metabolism, and increase bone formation, and is expected to provide a new strategy and method for the treatment of osteoporosis.

Citing Articles

Focal Adhesion Kinase Alleviates Simulated Microgravity-Induced Inhibition of Osteoblast Differentiation by Activating Transcriptional Wnt/β-Catenin-BMP2-COL1 and Metabolic SIRT1-PGC-1α-CPT1A Pathways.

Bai Y, Wu Z, Leary S, Fang C, Yu M, Genth H Int J Mol Sci. 2025; 26(4).

PMID: 40004131 PMC: 11855299. DOI: 10.3390/ijms26041669.

Mechanism of histone demethylase KDM5A in osteoporotic fracture healing through epigenetic regulation of the miR-495/SKP2/Runx2 axis.

Li Z, Zhang J, Xu T, Hao Z, Li Y Mol Med. 2025; 31(1):65.

PMID: 39972431 PMC: 11837617. DOI: 10.1186/s10020-025-01098-5.

Shuanglongjiegu pill promoted bone marrow mesenchymal stem cell osteogenic differentiation by regulating the miR-217/RUNX2 axis to activate Wnt/β-catenin pathway.

Tan Y, Ju S, Wang Q, Zhong R, Gao J, Wang M J Orthop Surg Res. 2024; 19(1):617.

PMID: 39350234 PMC: 11443779. DOI: 10.1186/s13018-024-05085-0.

Sun L, Chen J, Li L, Li L PeerJ. 2024; 12:e18068.

PMID: 39308804 PMC: 11416762. DOI: 10.7717/peerj.18068.

Low-molecular-weight estrogenic phytoprotein suppresses osteoporosis development through positive modulation of skeletal estrogen receptors.

Kubi J, Brah A, Cheung K, Chen A, Lee Y, Lee K Bioact Mater. 2024; 42:299-315.

PMID: 39290337 PMC: 11405634. DOI: 10.1016/j.bioactmat.2024.08.045.

References

Pelled G, G T, Aslan H, Gazit Z, Gazit D . Mesenchymal stem cells for bone gene therapy and tissue engineering. Curr Pharm Des. 2002; 8(21):1917-28. DOI: 10.2174/1381612023393666. View

Takayama K, Nomura H, Tanaka J, Zborowski M, Harasaki H, Jacobs G . Effect of a pulsing electromagnetic field on metabolically derived osteoporosis in rats: a pilot study. ASAIO Trans. 1990; 36(3):M426-8. View

de Melo Ocarino N, Boeloni J, Jorgetti V, Gomes D, Goes A, Serakides R . Intra-bone marrow injection of mesenchymal stem cells improves the femur bone mass of osteoporotic female rats. Connect Tissue Res. 2010; 51(6):426-33. DOI: 10.3109/03008201003597049. View

Rodriguez J, Astudillo P, Rios S, Pino A . Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. Curr Stem Cell Res Ther. 2008; 3(3):208-18. DOI: 10.2174/157488808785740325. View

Yuan Q, Kubo T, Doi K, Morita K, Takeshita R, Katoh S . Effect of combined application of bFGF and inorganic polyphosphate on bioactivities of osteoblasts and initial bone regeneration. Acta Biomater. 2009; 5(5):1716-24. DOI: 10.1016/j.actbio.2009.01.034. View

Komm B, Terpening C, Benz D, Graeme K, Gallegos A, Korc M . Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science. 1988; 241(4861):81-4. DOI: 10.1126/science.3164526. View

Tsai M, Li W, Tuan R, Chang W . Modulation of osteogenesis in human mesenchymal stem cells by specific pulsed electromagnetic field stimulation. J Orthop Res. 2009; 27(9):1169-74. PMC: 2746855. DOI: 10.1002/jor.20862. View

Rodriguez J, Montecinos L, Rios S, Reyes P, Martinez J . Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem. 2000; 79(4):557-65. DOI: 10.1002/1097-4644(20001215)79:4<557::aid-jcb40>3.0.co;2-h. View

Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S . Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood. 2005; 105(10):3793-801. DOI: 10.1182/blood-2004-11-4349. View

10.

Zhuang H, Zhang X, Zhu C, Tang X, Yu F, Shang G . Molecular Mechanisms of PPAR-γ Governing MSC Osteogenic and Adipogenic Differentiation. Curr Stem Cell Res Ther. 2015; 11(3):255-64. DOI: 10.2174/1574888x10666150531173309. View

11.

Cole Z, Dennison E, Cooper C . Osteoporosis epidemiology update. Curr Rheumatol Rep. 2008; 10(2):92-6. DOI: 10.1007/s11926-008-0017-6. View

12.

Gimble J, Zvonic S, Floyd Z, Kassem M, Nuttall M . Playing with bone and fat. J Cell Biochem. 2006; 98(2):251-66. DOI: 10.1002/jcb.20777. View

13.

Kang M, Lee W, Oh K, Han J, Song K, Cha B . The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone. 2000; 26(3):275-9. DOI: 10.1016/s8756-3282(99)00265-3. View

14.

Kimura Y, Tabata Y . Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed. 2009; 21(1):37-51. DOI: 10.1163/156856209X410193. View

15.

Rodan G, Harada S . The missing bone. Cell. 1997; 89(5):677-80. DOI: 10.1016/s0092-8674(00)80249-4. View

16.

Ma X, Cui D, Zhao D . Vascular endothelial growth factor/bone morphogenetic protein-2 bone marrow combined modification of the mesenchymal stem cells to repair the avascular necrosis of the femoral head. Int J Clin Exp Med. 2015; 8(9):15528-34. PMC: 4658933. View

17.

Nuttall M, Gimble J . Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol. 2004; 4(3):290-4. DOI: 10.1016/j.coph.2004.03.002. View

18.

Zhao T, Zhang D, Millard R, Ashraf M, Wang Y . Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling. Am J Physiol Heart Circ Physiol. 2009; 296(4):H976-86. PMC: 2670700. DOI: 10.1152/ajpheart.01134.2008. View

19.

Centeno C, Busse D, Kisiday J, Keohan C, Freeman M, Karli D . Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008; 11(3):343-53. View

20.

Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R . Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology. 1997; 138(10):4456-62. DOI: 10.1210/endo.138.10.5425. View